Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
SS Innovations (NASDAQ: SSII) reports 79% growth in SSi Mantra robotic procedures, now in 12 countries with 238 systems installed. FDA review expected by Q1 2027, EU certification targeted for year-end 2026. #RoboticSurgery #MedTech
2026-09-10T17:03:42.465Z